Showing results (341-350 of 521) with videos related to
Sort By:
Pageof 53
The Journal of Experimental Medicine|March 2, 1999
Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytesP Chaux, V Vantomme, V Stroobant, et al.Leukemia|April 1, 1997
CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory moleculesL E Van den Hove, S W Van Gool, P Vandenberghe, et al.Vaccines|August 10, 2019
Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine ProductionKatrijn Broos, Quentin Lecocq, Brenda De Keersmaecker, et al.ACS Nano|May 28, 2021
Multicomponent Covalent Chemical Patterning of GrapheneMiriam C Rodríguez González, Alessandra Leonhardt, Hartmut Stadler, et al.Polymers|December 18, 2019
Cellulose-Cyclodextrin Co-Polymer for the Removal of Cyanotoxins on Water SourcesDiego Gomez-Maldonado, Iris Beatriz Vega Erramuspe, Ilari Filpponen, et al.Cancer Research|May 17, 2008
Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalitiesThierry Connerotte, Aline Van Pel, Danièle Godelaine, et al.Immunology|June 9, 1998
Immunoglobulin VH gene sequence analysis of spontaneous murine immunoglobulin-secreting B-cell tumours with clinical features of human diseaseD Zhu, C van Arkel, C A King, et al.Journal of Translational Medicine|July 27, 2019
Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in micePatrick Tjok Joe, Ioanna Christopoulou, Lien van Hoecke, et al.British Journal of Haematology|February 1, 1997
Persistence of residual tumour cells after cytokine-mediated ex vivo expansion of mobilized CD34+ blood cells in multiple myelomaI Van Riet, N Juge-Morineau, R Schots, et al.Oncotarget|October 23, 2014
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunityKevin Van der Jeught, Patrick Tjok Joe, Lukasz Bialkowski, et al.Pageof 53